Xcout IntelSign inSubscribe

Amneal Pharmaceuticals, Inc. competitors & alternatives

AMRXPharmaceuticalsBridgewater, United States

The 12 closest competitors and alternatives to Amneal Pharmaceuticals, Inc. among pharmaceuticals companies — ranked by similarity to what Amneal Pharmaceuticals, Inc. actually does, not by market-cap band.

$6.4BMarket cap
8,300Employees
12Competitors listed

Subscribe to see Amneal Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications, topical applications, softgels, inhalants, and transdermal patches, all catering to a broad spectrum of medical needs. Within the Specialty division, the company concentrates on the advancement, marketing, sales, and distribution of proprietary branded pharmaceuticals. Key therapeutic areas for this segment include neurological conditions, endocrine disorders, and parasitic ailments, among others. Notable offerings include Emverm, a chewable tablet prescribed for single or mixed parasitic infections such as pinworm and various hookworms; Rytary, designed for the management of Parkinson's disease; and Unithroid, used in treating hypothyroidism. The AvKARE segment primarily serves governmental entities, particularly the Department of Defense and the Department of Veterans Affairs, supplying them with pharmaceuticals, medical and surgical supplies, and related services. Additionally, this segment engages in the bulk distribution of bottled and unit-dose pharmaceuticals under its AvKARE and AvPAK brands, alongside medical and surgical items. It also manages the packaging and large-scale distribution of medications and nutritional supplements for its retail and institutional clientele. Products from Amneal reach consumers through a network comprising wholesale suppliers, third-party distributors, hospitals, large pharmacy chains, and independent drugstores. Its operational footprint extends across the United States, India, Ireland, and other international markets. Established in 2002, the company was initially incorporated as Atlas Holdings, Inc., before adopting the name Amneal Pharmaceuticals, Inc. in 2018. Its corporate headquarters are situated in Bridgewater, New Jersey.

Amneal Pharmaceuticals, Inc. at a glance

Amneal Pharmaceuticals, Inc. is a pharmaceuticals company headquartered in Bridgewater, United States. It is publicly listed (AMRX) with a market capitalisation of $6.4B. Xcout tracks 26 named people at Amneal Pharmaceuticals, Inc., including Anastasios G. Konidaris (Executive Vice President & Chief Financial Officer). Xcout recorded 107 job postings from Amneal Pharmaceuticals, Inc. in the last 90 days.

Amneal Pharmaceuticals, Inc. leadership

  • Anastasios G. KonidarisExecutive Vice President & Chief Financial Officer
  • Andrew S. BoyerExecutive Vice President and Chief Commercial Officer of Generics & Biosciences
  • Jason DalyExecutive Vice President, Chief Legal Officer & Corporate Secretary
  • Nikita ShahExecutive Vice President & Chief Human Resources Officer
  • Sanjay Kumar JainChief Quality Officer
  • Chintu PatelCo-Founder, Co-CEO & Director

20 more named people on record for Amneal Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →

Hiring at Amneal Pharmaceuticals, Inc.

Xcout recorded 107 job postings from Amneal Pharmaceuticals, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.

The weekly hiring trend, the roles and locations behind it — see Amneal Pharmaceuticals, Inc.'s hiring signals →

Recent Amneal Pharmaceuticals, Inc. news

3 corporate events on record, with sources — see the full timeline →

Top 12 Amneal Pharmaceuticals, Inc. competitors

Ranked by semantic similarity — how close each company is to Amneal Pharmaceuticals, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Bausch Health Companies Inc.BHC · PharmaceuticalsLaval, Canada
64% matchPublic

Similar pharmaceuticals company

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Market cap$1.8B
Employees20,300
Bausch Health Companies Inc. competitors & alternatives →
Perrigo Company plc0Y5E · PharmaceuticalsDublin, Ireland
63% matchPublic

Similar pharmaceuticals company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Market cap$1.8B
Employees8,100
Perrigo Company plc competitors & alternatives →
TEVATEVA · PharmaceuticalsTel Aviv, Israel
63% matchPublic

Similar pharmaceuticals company

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic domains: central nervous system disorders, pain management, respiratory ailments, and oncology. In the central nervous system sector, prominent products include Copaxone, intended for relapsing forms of multiple sclerosis; AJOVY, prescribed for preventing migraines; and AUSTEDO, which targets tardive dyskinesia and chorea linked to Huntington's disease. For respiratory conditions, Teva offers medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all designed to treat asthma and chronic obstructive pulmonary disease. The oncology portfolio features therapies like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited is also engaged in a collaboration with MedinCell to advance and commercialize multiple long-acting injectable formulations, notably a risperidone suspension for individuals affected by schizophrenia. The company was established in 1901 and its primary headquarters are located in Tel Aviv-Yafo, Israel.

Market cap$45.8B
Employees37,000
TEVA competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Amneal Pharmaceuticals, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Amneal Pharmaceuticals, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →